New Approaches to Assessing and Treating Early-stage Colon and Rectal Cancer
January 2007
This program of multidisciplinary leaders in colon and rectal cancer research and treatment was directed by Lee S. Rosen, MD, Premiere Oncology, and Anton J. Bilchik, MD, PhD, FACS, John Wayne Cancer Institute.
Educational Objectives
(1) Discuss current approaches and issues in diagnosing and defining stage II disease; (2) discuss how surgeons can contribute to preoperative staging and postsurgical assessment and treatment decisions; (3) discuss criteria for determining when adjuvant chemotherapy is appropriate in early-stage disease; and (4) discuss criteria for determining when biologic therapy is appropriate in early-stage disease.
Educational Grant Support
This program is supported by educational grants provided by: sanofi-aventis US, Hoffmann-La Roche, Amgen, Inc., Bristol-Myers Squibb/ ImClone and Genentech.
Sponsorship
CME sponsorship and program management are provided by InforMEDical.
The conference proceedings were published as a peer-reviewed CME supplement to Clinical Cancer Research, November 15, 2007, Vol 13 (22 Suppl), 6853s-6856s.
The CME activity based on the publication summary is effective November 2007 through November 2008.
Journal Website
(subscription may be required to access full journal supplement)
